Ixekizumab
Product Specifications
CAS Number
1143503-69-8
Target
IL Receptor, Interleukin
Related Pathways
Immunology/Inflammation
Purity
>99.3%
Bioactivity
Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A with a Kd value of <3 pM. It blocks the binding of IL-17A to IL-17RA but not to other IL-17 family members. Ixekizumab is used for the treatment of moderate to severe plaque psoriasis, psoriasis, arthritis, and psoriasis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1372192-01 0.02 mg (E-Coli)
Recombinant Candida albicans Probable kinetochore protein SPC24 (SPC24)
Sign In for Pricing
View Details MBS1372192-02 0.1 mg (E-Coli)
Recombinant Candida albicans Probable kinetochore protein SPC24 (SPC24)
Sign In for Pricing
View Details MBS1372192-03 0.02 mg (Yeast)
Recombinant Candida albicans Probable kinetochore protein SPC24 (SPC24)
Sign In for Pricing
View Details MBS1372192-04 0.1 mg (Yeast)
Recombinant Candida albicans Probable kinetochore protein SPC24 (SPC24)
Sign In for Pricing
View Details MBS1372192-05 0.02 mg (Baculovirus)
Recombinant Candida albicans Probable kinetochore protein SPC24 (SPC24)
Sign In for Pricing
View Details MBS1372192-06 0.02 mg (Mammalian-Cell)
Recombinant Candida albicans Probable kinetochore protein SPC24 (SPC24)
Sign In for Pricing
View Details